Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT03239054

Prescribing Exercise as Medicine in Pregnancy

Prescribing Exercise as Medicine in Pregnancy: A Randomized Controlled Trial

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
St. Louis University · Academic / Other
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Not accepted

Summary

This study is a randomized controlled parallel arms trial. The purpose of this study is to evaluate if prescribing exercise in pregnancy can change maternal behavior towards exercise.

Detailed description

This study is a randomized controlled parallel arms trial. The purpose of this study is to evaluate if prescribing exercise in pregnancy can change maternal behavior towards exercise. Once screened and consented, participants will be randomized to either the intervention or control group in a 1:1 fashion. The intervention group will receive the PARMED-X prescription and the control group will receive routine care as usual. Physical activity will be monitored with a Polar fitness tracking device. Maternal and neonatal outcomes will be collected from the electronic medical record. Maternal outcomes include demographics, total gestational weight gain, pre-pregnancy body mass index (BMI), BMI at the time of delivery, mode of delivery, glucose screen value, presence or absence of gestational diabetes and presence or absence of hypertensive disorders of pregnancy. Neonatal outcomes include gestational age at delivery, birth weight, Apgar scores, arterial cord blood gases. Psychological outcomes will also be assessed using several validated scales in pregnancy including The Edinburgh Postnatal Depression Scale (EPDS) and The State Trait Anxiety Inventory (STAI).

Conditions

Interventions

TypeNameDescription
BEHAVIORALPhysical activitypregnancy prescription for physical activity as part of prenatal care can increase healthy exercise behaviors during pregnancy
BEHAVIORALControl groupInformation will be given as part of standard care

Timeline

Start date
2018-07-01
Primary completion
2020-08-31
Completion
2020-12-01
First posted
2017-08-03
Last updated
2018-08-02

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03239054. Inclusion in this directory is not an endorsement.